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High-frequency stimulation of skeletal muscle has long been associ-
ated with ionic perturbations, resulting in the loss of membrane
excitability, which may prevent action potential propagation and
result in skeletal muscle fatigue. Associated with intense skeletal
muscle contractions are large changes in muscle metabolites. How-
ever, the role of metabolites in the loss of muscle excitability is not
clear. The metabolic state of isolated rat extensor digitorum longus
muscles at 30°C was manipulated by decreasing energy expenditure
and thereby allowed investigation of the effects of energy conserva-
tion on skeletal muscle excitability. Muscle ATP utilization was
reduced using a combination of the cross-bridge cycling blocker
N-benzyl-p-toluene sulfonamide (BTS) and the SR Ca2 release
channel blocker Na-dantrolene, which reduce activity of the myosin
ATPase and SR Ca2-ATPase. Compared with control muscles, the
resting metabolites ATP, phosphocreatine, creatine, and lactate, as
well as the resting muscle excitability as measured by M-waves, were
unaffected by treatment with BTS plus dantrolene. Following 20 or
30 s of continuous 60-Hz stimulation, BTS-plus-dantrolene-treated
muscles showed a 25% lower ATP utilization compared with control
muscles. Furthermore, the ability of muscles to maintain excitability
during high-frequency stimulation was significantly improved in
BTS-plus-dantrolene-treated muscles, indicating a strong link be-
tween metabolites, energetic state, and the excitability of the muscle.
metabolites; endurance; adenosine triphosphate
IN SKELETAL MUSCLE, the signal for muscle contraction involves
the propagation of action potentials along the sarcolemma and
down the transverse tubules (T tubules), where it causes
activation of the voltage sensor molecules, subsequent SR
Ca2 release, and ultimately cross-bridge cycling (28), a pro-
cess known as excitation-contraction coupling. Skeletal muscle
fatigue, where the force generating ability of the muscle is
compromised, is a complex phenomenon that may occur at any
of the above-mentioned steps depending on the type of work
and the conditions under which it takes place.
The loss of force in isolated muscles stimulated to contract
tetanically is strongly correlated to a reduction in muscle
excitability (13, 31), indicating that loss of excitability may be
of particular importance in fatigue during intense contractions
involving high frequencies of action potentials. The etiology of
this reduction in muscle excitability is not fully clear, but it has
long been postulated to be related to a loss of intracellular K
from the muscle fibers, leading to a lowered concentration
gradient for K. Thus, in humans, maximal exercise results in
a rapid increase in arterial plasma K from 4 to 8 mM (27),
which is elevated to 10–12 mM in the muscle interstitium (29).
The result is depolarization of the muscle fibers, leading to
slow inactivation of the voltage-gated Na channels, which
prevents the initiation of action potential propagation (6, 12,
37), resulting in muscle fatigue.
Another important consequence of intense contractions is
the large change in the metabolic status of the working muscle,
with decreased intracellular ATP and phosphocreatine (PCr)
and increased creatine (Cr), H, lactate, ADP, and AMP. There
is now a vast amount of evidence implicating the role of
metabolites in skeletal muscle fatigue (for reviews, see Refs.
18 and 40), with much of this focusing on the effects of
metabolites on the contractile apparatus and on SR Ca2
cycling. In contrast, very little is known about the role that
metabolites play in the loss of muscle excitability. However,
since experiments with metabolic poisoning show that the
function of many ion channels is sensitive to severe metabolic
exhaustion (9, 16, 17), it is possible that metabolically-induced
changes in excitability contribute to the development of fatigue
during intense contractions.
The aim of this study was, therefore, to examine whether the
loss of excitability during intense contractions is influenced by
the metabolic status of muscles. Specifically, the effect of
energy conservation on the maintenance of muscle excitability
was investigated. Here, we reduced muscle ATP utilization
using a combination of the cross-bridge cycling blocker N-
benzyl-p-toluene sulphonamide (BTS) and the SR Ca2 release
channel blocker Na dantrolene, which reduces SR Ca2 release
and, therefore, activity of the myosin ATPase and SR Ca2-
ATPase. In such muscles, resting excitability was unaffected;
however, the maintenance of excitability during high-fre-
quency stimulation was significantly improved.
METHODS
Animals, preparation, and incubation of muscles. All handling and
use of animals complied with Danish animal welfare regulations, and
the euthanasia was approved by the University Animal Welfare
Office. Experiments were performed using 4-wk-old Wistar rats,
weighing 70–75 g, that were kept in a thermostated environment at
21°C with a 12:12-h light-dark cycle and fed ad libitum. The animals
were killed by cervical dislocation, followed by decapitation. Intact
extensor digitorum longus muscles (weight 20–25 mg, radius 0.70
mm) were prepared and incubated in standard Krebs-Ringer bicar-
bonate buffer (KRB) containing the following (in mM): 122.1 NaCl,
25.1 NaHCO3, 2.8 KCl, 1.2 KH2PO4, 1.2 MgSO4, 1.3 CaCl2, and 5.0
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D-glucose (pH 7.4). All incubations took place at 30°C under contin-
uous gassing with a mixture of 95% O2 and 5% CO2.
Measurement of force and compound action potentials (M-waves).
Muscles were mounted for isometric contractions in thermostated
chambers containing standard KRB and adjusted to optimal length for
force production. After a 30-min equilibration period, muscles were
exposed to field stimulation across the central region through platinum
electrodes using 0.5-s trains of 0.02-ms, 12-V pulses at 60 Hz every
20 min. Force was measured using force displacement transducers and
recorded with a chart recorder and/or digitally on a computer. Fatigu-
ing stimulation involved stimulating the muscles continuously for 20
or 30 s at 60 Hz, using 0.02-ms trains of 12-V pulses. The mean
absolute force produced under control conditions was 0.30  0.03 N
(n  70), with results expressed as a percentage of the control force
produced directly prior to treatment.
Immediately following fatiguing stimulation, the chamber was
lowered and the muscle detached and frozen in liquid N2 for assess-
ment of metabolites. The resulting metabolite values measured in the
muscle represent those at the end of contraction. Control measure-
ments, in which a thermocouple (copper-constantan, od  0.4 mm;
California FineWire, Grover City, CA) was placed in the central part
of the muscles, showed that the time that elapsed from the cessation
of the stimulation until the core of the muscles was cooled to 0°C was
4.0  0.8 s (n  8). A sample of the buffer was also frozen for
determination of lactate released into the solution during the fatiguing
stimulation.
Muscle excitability was determined by recording compound action
potential signals (M-waves) from a polyimide-insulated tungsten
electrode (TM33B01; World Precision Instruments, Sarasota, FL)
placed within the muscle between the innervation zone and the
tendon. Signals were sent to a DAM 70 differential amplifier mounted
with a low-noise headstage (World Precision Instruments) and then
recorded digitally on a computer. The M-wave area was defined as the
area between the baseline and the major negative peak of the M-wave
trace, whereas the M-wave amplitude was defined as the maximal
voltage of the negative peak, as previously described by Overgaard
et al. (31). M-wave area and amplitude were analyzed every 2 s during
fatiguing stimulation. At each time point, the area and amplitude of
five successive M-waves was averaged, with the mean coefficient of
variation from successive M-waves being 4.2  0.4 (n  60) and
3.7  0.5% (n  60) for M-wave area and M-wave amplitude,
respectively. Control experiments were performed and showed that
insertion of the M-wave electrode into the muscle did not significantly
alter force production (98  4% of controls, P  0.231, n  8).
Manipulation of muscle ATP consumption. To alter the ATP
consuming processes occurring during muscle contraction, two phar-
macological agents were employed. The first, BTS (50 M), signif-
icantly reduces tetanic force production by specifically blocking
cross-bridge cycling of myosin type II contractile proteins (10) with-
out altering either Ca2 transients (15, 7) or muscle excitability (25).
The second, Na dantrolene (dantrolene, 25 M), significantly reduces
tetanic force (34, 43) by inhibiting the SR Ca2 release channels
without markedly altering muscle excitability (41), which in turn
reduces both the myosin ATPase and the SR Ca2-ATPase activities.
BTS and dantrolene were used individually or in combination and
were added from stocks dissolved in DMSO, with the corresponding
amount of DMSO added to controls.
Measurement of muscle metabolites. Muscle metabolites were
measured in muscles that were frozen in liquid N2 following the
cessation of fatiguing stimulation, whereas resting metabolites were
measured from contralateral muscles treated the same, except that
they did not undergo fatiguing stimulation. Frozen muscle samples
were later freeze-dried, dissected free of nonmuscle tissue, and pow-
dered. Muscle extracts were analyzed for ATP, ADP, AMP, PCr, Cr,
lactate, and pyruvate concentrations as previously described (21). To
adjust for variability in solid nonmuscle constituents and weighing
variability, values were divided by the total amount of Cr (PCr  Cr)
and multiplied by the mean of total Cr for the whole material (22).
BTS plus dantrolene did not significantly affect total Cr, with total Cr
averaging 128  9 and 133  8 mmol/kg dry wt (n  18, P  0.159)
for control and BTS-plus-dantrolene-treated muscles, respectively.
Intracellular pH (pHi) was determined using the equation pHi 
7.06  0.00532 ([lactate]  [pyruvate]) (22). ATP utilization was
calculated using the following equation: ATP utilization  2
(ATP)  PCr  (1.5 lactate), where  refers to the difference
between the stimulation value and the resting value from the con-
tralateral muscle under control and BTS-plus-dantrolene conditions,
respectively.
Chemicals. All chemicals were of analytical grade. Na dantrolene
was obtained from Sigma-Aldrich and BTS from Toronto Research
Chemicals (Toronto, ON, Canada).
Statistics. All data were expressed as means  SD and statistical
analyses were performed using GraphPad Prism (GraphPad Software,
San Diego, CA). The statistical significance of any difference between
groups was accepted at P  0.05, as determined using Student’s
two-tailed t-test for nonpaired observations or ANOVA, with differ-
ences located with Student-Newman-Keuls post hoc test, where ap-
propriate.
RESULTS
Tetanic force and muscle excitability. Because muscle ex-
citability was measured extensively during this study, it was
important to first show that BTS and dantrolene did not
significantly alter resting muscle excitability while reducing
tetanic force and thus also reducing muscle ATP utilization.
Figure 1A shows that, over a 120-min period under control
conditions, there was no significant alteration in tetanic force
(P  0.075), M-wave area (P  0.628), or M-wave amplitude
(P  0.233). Figure 1, B–D, shows the effects of 50 M BTS,
25 M dantrolene, and a combination of both 50 M BTS plus
25 M dantrolene, respectively, on tetanic force and on M-
wave parameters. The combination of BTS plus dantrolene
induced the fastest and largest reduction in tetanic force to
2% of initial tetanic force at 120 min (P  0.001; Fig. 1D).
Importantly, neither BTS (P 0.963 and 0.123) nor dantrolene
(P  0.969 and 0.409), nor the combination of BTS plus
dantrolene (P  0.993 and 0.230), significantly reduced M-
wave area or M-wave amplitude, indicating that there was no
marked effect on muscle excitability.
Force production during fatiguing stimulation. Representa-
tive traces of the effect of BTS, dantrolene, and the combina-
tion of BTS plus dantrolene on force production during 30-s,
60-Hz continuous stimulation are shown in Fig. 2A. The
combination of BTS plus dantrolene was by far the most
effective at reducing force production and, therefore, probably
ATP utilization. Control muscles and those treated with a
combination of BTS plus dantrolene were thus compared in all
subsequent experiments. Summarized data showing force pro-
duction during 30-s, 60-Hz continuous stimulation of control
and BTS-plus-dantrolene-treated muscles are shown in Fig. 2B.
In control muscles, force was maintained for the first 10 s of
stimulation (all P 	 0.05) before steadily declining to 20% of
initial force at the end of stimulation (P  0.001). The
combination of BTS plus dantrolene prevented 	95% of the
force production during 30-s, 60-Hz continuous stimulation,
with the force being significantly lower than in control muscles
throughout the stimulation period (all P  0.001).
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Muscle metabolism. Figures 3, 4, and 5 show that the resting
values for ATP, PCr, Cr, and lactate are unchanged by 60-min
incubation with BTS plus dantrolene (P 0.947, 0.349, 0.349,
and 0.249, respectively). In control muscles, stimulation for 20
or 30 s resulted in a significant reduction in ATP, by 50 (P 
0.001) and 55% (P  0.001), respectively (Fig. 3). By com-
parison, in the presence of BTS plus dantrolene, ATP was
reduced by only 7 (P  0.004) and 15% (P  0.001) at 20 and
30 s, respectively. After 20 and 30 s of continuous 60-Hz
stimulation, the PCr levels in control muscles were signifi-
cantly reduced by 65 (P  0.001) and 67% (P  0.001),
respectively, and were not altered by the presence of BTS plus
dantrolene (20 s, 61%, P  0.001; 30 s, 69%, P  0.001; Fig.
4A). In line with the large reductions in PCr during stimulation,
there was a large, significant increase in Cr at both 20 (P 
0.001) and 30 s (P  0.001) for controls and BTS-plus-
dantrolene-treated muscles (P  0.001 and P  0.001; Fig.
4B). The effect of continuous 60-Hz stimulation on lactate
production is shown in Fig. 5. Following 20- and 30-s stimu-
lation, lactate significantly increased from 1 to 60 (P 
0.001) and 80 mmol/kg dry wt (P  0.001) in control
muscles, whereas in BTS-plus-dantrolene-treated muscles, lac-
tate significantly increased to 40 (P  0.001) and 55
mmol/kg dry wt (P  0.001), respectively. Table 1 shows that
there was a small but significant (all P  0.02) release of
lactate from the muscle into the buffer during the continuous
stimulation. These values are included in the lactate values in
Fig. 5. Resting pyruvate levels were the same in control and
BTS-plus-dantrolene-treated muscles (P  0.101), with large,
significant stimulation-induced increases in pyruvate in both
control (P  0.001) and BTS-plus-dantrolene-treated muscles
(P 0.001). Using the values for lactate and pyruvate, pHi was
estimated following stimulation, and, as indicated in Table 1,
pHi fell to a lower level in control muscles than in BTS-plus-
dantrolene-treated muscles. Table 1 also shows that there were
significant stimulation-induced increases in ADP in both con-
trol (P  0.001) and BTS-plus-dantrolene-treated muscles
(P  0.001). There were no significant alterations to the AMP
levels during 20- or 30-s continuous stimulation (all P 	 0.05)
in control or BTS-plus-dantrolene-treated muscles.
Using these values, it was possible to estimate the ATP
utilization during 30-s, 60-Hz stimulation in control and BTS-
plus-dantrolene-treated muscles. Control muscles that under-
went continuous 60-Hz stimulation for 30 s had an ATP
utilization of 221  12 mmol/kg dry wt, which was signifi-
cantly higher (P  0.001) than that of BTS-plus-dantrolene-
treated muscles (165  22 mmol/kg dry wt), demonstrating a
25% conservation of energy in BTS-plus-dantrolene-treated
muscles.
Muscle excitability during fatiguing stimulation. The overall
excitability of the muscles during the 30 s of 60-Hz continuous
stimulation was assessed by measurements of M-wave area and
amplitude. As shown in Fig. 6, the area of the M-wave in
control muscles increased progressively during the first 16 s of
stimulation before rapidly declining to 15% of initial level at
30 s of stimulation. A similar, two-phased development was
observed in the M-wave amplitude, which showed a slow
decline during the first 10 s of stimulation before steadily
decreasing at a faster rate to 10% of initial level at 30 s of
stimulation (Fig. 6B). In BTS-plus-dantrolene-treated muscles,
Fig. 1. The effect of N-benzyl-p-sulfonamide (BTS)
and dantrolene on tetanic force and muscle excitability
(M-waves) under control conditions. Simultaneous re-
cordings of tetanic force (F), M-wave area (E), and
M-wave amplitude () measured every 20 min, during
60-Hz, 0.5-s tetanic contractions in control (A), 50 M
BTS- (B), 25 M dantrolene- (C), and 50 M BTS 
25 M dantrolene-treated muscles (D). BTS and dan-
trolene were added at time 40 min. Data points are
means  SD and are normalized to pretreatment re-
sponses (n  4). *Significant difference (P  0.001)
from pretreatment (40 min) responses.
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M-wave area increased for the first 20 s of stimulation (all P	
0.05) before declining to 50% of initial value at 30 s (P 
0.001). Due to the later onset of the decline, the M-wave area
was significantly larger in BTS-plus-dantrolene-treated mus-
cles than in controls from 20 s of stimulation and onward (all
P  0.05). Similarly, the onset of the fast decline in M-wave
amplitude was delayed in muscles treated with BTS plus
dantrolene, leading to a significantly larger M-wave amplitude
in BTS-plus-dantrolene-treated than control muscles from 18 s
and onward during the 30-s, 60-Hz stimulation (all P  0.05).
DISCUSSION
The major observation of this study was that, in fast-twitch
muscles, preincubation with BTS plus dantrolene significantly
reduced ATP utilization (conserved energy status) during con-
tinuous high-frequency stimulation and at the same time im-
proved the maintenance of excitability, indicating that the loss
of muscle excitability during intense exercise is hastened if the
muscles experience metabolic exhaustion.
BTS plus dantrolene and force production. Individually,
both BTS (10, 15, 25) and dantrolene (34, 43) have previously
been shown to reduce tetanic force in fast-twitch skeletal
muscle; however, this is the first study to combine these two
compounds. In the present study, BTS and dantrolene alone
were effective at reducing tetanic force during short contrac-
tions; however, the increase in force observed in Fig. 2A after
5 s of continuous stimulation demonstrates that the inhibition
of the myosin ATPase by BTS was partially overcome during
longer contractions. Even more striking was that, during longer
contractions, the effect of dantrolene-induced inhibition of SR
Ca2 release appears to be removed, resulting in a substantial
increase in force production (Fig. 2A). The exact mechanisms
for these losses of inhibition are not clear, although, in the case
of dantrolene, it is possibly via a Ca2-induced activation of
the SR Ca2 release channels.
Muscle metabolites. There was no difference in resting
metabolites of control or BTS-plus-dantrolene-treated muscles.
Importantly, our resting metabolite results are similar to those
of adult rat extensor digitorum longus muscles, determined by
freeze-clamping with aluminium tongs cooled in liquid N2
(36). However, following continuous stimulation for 20 or 30 s
at 60 Hz, muscles pretreated with BTS plus dantrolene had a
smaller reduction in ATP and increase in lactate and, therefore,
a lower ATP utilization than controls. Rather surprisingly, in
control muscles the ATP and PCr levels observed after 30-s
stimulation were not lower than after 20-s stimulation. How-
ever, the lactate was considerably elevated. In the BTS-plus-
dantrolene muscles, 30-s stimulation reduced ATP to a lower
level than after only 20 s, although there was also a large
increase in lactate from 20 to 30 s. Despite the clear conser-
vation of ATP in BTS-plus-dantrolene-treated muscles, the
depletion in PCr, as well as the concomitant increase in Cr, was
the same in both control and BTS-plus-dantrolene-treated mus-
cles. It is important to consider that some metabolism may still
Fig. 2. The effect of BTS and dantrolene on force production during 30-s,
60-Hz continuous stimulation. A: representative traces of control muscles and
those treated with 50 M BTS, 25 M dantrolene (dan), or 50 M BTS  25
M dantrolene (BTS  dan) as indicated in the figure. Similar results were
observed in 5 other muscles with corresponding treatments. B: summarized
data from 6 muscles showing force production in control (F) and 50 M
BTS  25 M dantrolene-treated muscles (E). For the sake of clarity, data
points are means  SD and are normalized to pretreatment responses (n  6).
*P  0.001; #P  0.01 from controls. BTS and dantrolene were added 60 min
prior to stimulation.
Fig. 3. ATP at rest and following 20 and 30 s of 60-Hz continuous stimulation.
Filled bars, control muscles; open bars, muscles treated with 50 M BTS 25
M dantrolene for 60 min prior to stimulation. To adjust for variability in solid
nonmuscle constituents and weighing variability, values were divided by the
total amount of creatine [phosphocreatine (PCr)  creatine (Cr)] and multi-
plied by the mean of total creatine for the whole material. Values are means 
SD for 6 muscles. *P  0.001 from rest; $P  0.004 from rest; #P  0.002
from 20 s; §P  0.001 from control 20 s; £P  0.001 from control 30 s.
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be occurring in the muscles during the time from the cessation
of stimulation to the muscle being frozen. Despite this, it is
clear that the addition of BTS plus dantrolene substantially
conserves the energy status of the muscle.
Muscle excitability. Importantly, neither BTS nor dantrolene
alone, nor the combination of BTS plus dantrolene, altered
resting muscle excitability (Fig. 1). This is in agreement with
a previous study showing that BTS does not markedly alter
M-waves or intracellularly recorded action potentials (25).
Dantrolene has also been shown to have little effect of muscle
excitability, since it does not alter resting membrane potential
or action potential parameters (41), although it has been shown
to cause a small increase in the rheobase current required to
trigger an action potential (30).
In accord with other studies on muscles exposed to high-
frequency stimulation (13, 31), M-wave area and amplitude
were, in the present study, well maintained during the first
seconds of 60-Hz stimulation (Fig. 6) but then declined at a fast
rate as stimulation was continued. A similar, two-phased de-
velopment was observed in the force production of control
muscles (Fig. 2), and Fig. 7 shows that, in these muscles, force
was significantly correlated to both M-wave area (r2  0.61,
P  0.001) and M-wave amplitude (r2  0.89, P  0.001)
during the 30-s of 60-Hz continuous stimulation. Thus, as
shown in other studies on isolated muscles (13, 31), the loss of
excitability significantly contributes to the fatigue development
in these muscles. Since muscles treated with BTS plus dan-
trolene produced very little force, it was not possible to
examine the correlation between excitability and fatigue in
these muscles, but the main observation in this study was that
BTS-plus-dantrolene-treated muscles, which have a conserved
energy status, also show a marked delay in the fast loss of
excitability late in the experiment (Fig. 6). Thus, after 20 s of
stimulation in control muscles, there was a large decrease in
ATP and increase in lactate, with corresponding reductions in
M-wave area and amplitude of 50 and 70%, respectively. At
the same 20-s time point, BTS-plus-dantrolene-treated muscles
had much higher ATP and lower lactate than controls and
showed no reduction in M-wave area and only a 30% decrease
in M-wave amplitude. These results strongly suggest that the
loss of muscle excitability during intense exercise is hastened
if muscles experience metabolic exhaustion. In support of this
conclusion, previous observations point to several mechanisms
that may convey a link between energy status and excitability
in skeletal muscles.
Generally, the loss of muscle excitability during intensive
contractions has been related to the loss of intracellular K and
the accumulation of extracellular K (see Refs. 11 and 37).
The resulting membrane depolarization leads to slow inactiva-
tion of the voltage-gated Na channels (35) and eventually loss
of muscle excitability. The concomitant increase in intracellu-
lar Na will also reduce the driving force for the inward Na
current, which will further reduce action potential amplitude
(1). Comparison of sarcolemmal action potentials, before and
after fatiguing stimulation of frog skeletal muscle, shows a 10-
to 20-mV membrane depolarization, a 20- to 40-mV decrease
Fig. 4. PCr (A) and Cr (B) at rest and following 20 and 30 s of 60-Hz
continuous stimulation. Filled bars, control muscles; open bars, muscles treated
with 50 M BTS  25M dantrolene for 60 min prior to stimulation. To
adjust for variability in solid nonmuscle constituents and weighing variability,
values were divided by the total amount of Cr (PCr  Cr) and multiplied by
the mean of total Cr for the whole material. Values are means  SD for 6
muscles. *P  0.001 from rest.
Fig. 5. Lactate at rest and following 20 and 30 s of 60-Hz continuous
stimulation. Filled bars, control muscles; open bars, muscles treated with 50
M BTS  25 M dantrolene for 60 min prior to stimulation. To adjust for
variability in solid nonmuscle constituents and weighing variability, values
were divided by the total amount of Cr (PCr Cr) and multiplied by the mean
of total Cr for the whole material. Values are means SD for 6 muscles. *P
0.001 from rest; #P  0.001 from 20 s; §P  0.001 from control 20 s; £P 
0.001 from control 30 s.
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in action potential amplitude, and an approximate doubling in
the duration of the action potential (2, 24). However, in
agreement with the maintenance of M-wave area and ampli-
tude during the first seconds of 60-Hz stimulation shown in
Fig. 6, studies in which the concentration gradients for K and
Na have been changed in isolated muscles (8, 37) show that
a large safety margin exists that allows a substantial reduction
in the concentration gradients of the two ions to take place
before excitability is lost. Recently, it was shown (33) that this
tolerance of muscles to a reduction in the concentration gradi-
ents for Na and K is sensitive to changes in resting mem-
brane conductance, with a smaller loss of excitability at re-
duced membrane conductance. In this context, improved main-
tenance of excitability in BTS-plus-dantrolene-treated muscles
can be envisaged to involve effects of metabolites on the loss
of intracellular K and on the resting membrane conductance.
One possibility is that the loss of muscle excitability in
muscles with reduced energy status is accelerated by the
opening of ATP-sensitive K (KATP) channels that are in the
closed state at resting levels of ATP and open state at low ATP.
Davies et al. (14) showed that KATP channels were virtually
inactive at 3 mM ATP and exhibited only limited activity at 1
mM ATP; however, decreasing pHi from 7.2 to 6.3 resulted in
significant channel activity. However, Standen et al. (39) found
that KATP channels could be activated by lowering pHi to 6.45,
without reducing ATP, suggesting that a reduction in pHi alone
can also open KATP channels. The ATP level in control
muscles was markedly reduced (Fig. 3), and the large increase
in lactate (Fig. 4) was associated with a drop in pHi to 6.63
(Table 1), making it possible that KATP channels are activated.
Indeed, in frog skeletal muscle that has undergone chemically-
induced metabolic exhaustion, there is an increase in K
conductance that can be inhibited by the KATP channel blocker
glibenclamide (9). Opening of KATP channels would cause an
increase in both the K conductance and the K efflux. In
accord with this, pharmacological opening of KATP channels
with pinacidil reduces action potential overshoot and slows the
time course of the action potential (20). Furthermore, in iso-
lated muscles, pinacidil has been shown to decrease time to
fatigue (26) and accelerate the run down in M-waves associ-
ated with fatiguing stimulation (20). Although it is clear that
the opening of KATP channels increases the rate of fatigue, the
exact role of KATP channels during contractions is not so
obvious. Blocking KATP channels with glibenclamide does not
alter action potential parameters or prolong the time to fatigue
of isolated muscles (19).
Another possible mechanism for the improved maintenance
of excitability in BTS-plus-dantrolene-treated muscles could
be that the conserved energy status allows for a larger active
reuptake of K via the Na-K-ATPase, which would limit
the loss of intracellular K during contractions by improving
the leak pump ratio for the ion (23). However, the global ATP
values indicated in Fig. 3 should be sufficient to supply the
Table 1. Muscle metabolites following 60-Hz continuous stimulation
Metabolite
Control BTS  Dantrolene
Rest 20 s 30 s Rest 20 s 30 s
ADP 2.80.1 3.10.1* 2.90.1 3.10.1 3.40.1* 3.50.1*‡
AMP 0.10.1 0.10.1 0.10.1 0.10.1 0.10.1 0.10.1
Pyruvate 0.10.1 1.30.1* 1.30.1* 0.10.1 2.40.1*§ 2.40.1*£
Buffer lactate 1.70.9 3.00.7† 4.21.4* 2.20.4 2.40.9 3.61.2†
pHi 7.05 6.71 6.63 7.05 6.81 6.73
Values are means  SD for 6 muscles, and except for intracellular (pHi), all units are in mmol/kg dry wt. BTS, N-benzyl-p-toluene sulfonamide; BTS plus
dantrolene-treated muscles were exposed to 50 M BTS  25 M dantrolene for 60 min prior to stimulation. To adjust for variability in solid nonmuscle
constituents and weighing variability, values were divided by the total amount of creatine (phosphocreatine  creatine) and multiplied by the mean of total
creatine for the whole material. pHi was estimated from the regression equation pHi  7.06  0.00532 (lactate  pyruvate) (22), using the values from Table 1
and Fig. 5. *P  0.001 from rest; †P  0.02 from rest; ‡P  0.002 from 20 s; §P  0.001 from control 20 s; £P  0.001 from control 30 s.
Fig. 6. Muscle excitability (M-waves) during 30-s, 60-Hz continuous stimu-
lation. M-wave area (A) and M-wave amplitude (B) in control (F) and 50 M
BTS  25 M dantrolene-treated muscles (E). BTS plus dantrolene were
added 60 min prior to stimulation. For the sake of clarity, data points are
means  SD and are normalized to pretreatment responses (n  6). *P 
0.001; #P  0.01; §P  0.05 from controls.
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Na-K-ATPase, since it has a Km for ATP of 0.5 mM (18).
It is also conceivable that a large reduction in pHi will inhibit
the Na-K-ATPase (38), although de Paoli et al. (15a)
reported no alteration to Na-K-ATPase activity when pHi
was decreased to 6.8.
Ca2-activated K (KCa2) channels, which open in the
presence of high intracellular Ca2, may also provide a link
between energy status and muscle excitability. As with KATP
channels, opening of KCa2 channels would lead to a loss of
muscle excitability. In metabolically exhausted frog muscles,
Fink and Lu¨ttgau (16) showed a large increase in membrane
K conductance that could be prevented by the Ca2-chelating
agent EGTA, suggesting a role for KCa2 channels. They
suggested that metabolically exhausted fibers lose the ability to
control myoplasmic Ca2 and, furthermore, that the reduced
energy status may itself increase the membrane conductance
via opening of KCa2 channels. It is possible that dantrolene
prevents myoplasmic Ca2, increasing enough to activate K
Ca2 channels, and that the maintenance of muscle excitability
we observed is related to a lower myoplasmic Ca2 level.
However, Fig. 2 shows that muscles treated with dantrolene
alone still produce 70% of control force 10 s into the
stimulation, indicating that, despite the presence of dantrolene,
there must be a significant elevation in myoplasmic Ca2. It is
therefore unlikely that the maintenance of muscle excitability
we observed is associated with the lack of opening of the KCa2
channels.
Finally, Bennetts et al. (5) have suggested that the main
skeletal muscle Cl channel, the ClC-1 channel, is sensitive to
the energetic state of muscle fibers, and that ATP depletion
increases its open probability. Such a mechanism would result
in a high-membrane conductance in metabolically exhausted
fibers, which is in accord with studies on frog muscle (16)
showing that inhibition of ATP production causes the resting
Cl conductance to increase.
Implications for muscle function. It has long been suggested
(6, 11, 37) that loss of muscle excitability plays a role in
skeletal muscle fatigue, particularly during intensive work
involving high frequencies of action potentials. The present
study shows that if the work performed also causes a substan-
tially reduced energy status of the muscle, the loss of excit-
ability is hastened. Since the preparation used was an isolated
muscle without blood circulation that was stimulated to con-
tract tetanically for 30 s, this conclusion is relevant to work
involving static, intense contractions. The impedence of blood
flow during such contractions mimics the conditions of the
isolated muscle in two important aspects. First, the buildup of
K in the extracellular space of the muscle depends only on the
balance between the loss and the uptake of K from the muscle
fibers. Second, the energy requirements of the muscle fibers
must mainly be met by anerobic metabolism. During dynamic
work, where oxygen delivery to the muscles is increased, the
maintenance of the energy status is supported by oxidative
ATP production, and the energy status may never decrease to
reach levels that would cause a loss of excitability. A recent
study modeling oxygen consumption in contracting isolated
muscles (3) suggests that, even when oxygen is available,
anerobic metabolism is able to supply the extra energy require-
ments of contraction for at least the first 10 s. Therefore, it is
also plausible that intense exercise in vivo may cause a reduc-
tion in muscle excitability, even though the contractions are
dynamic.
An important implication for the role of excitability in
skeletal muscle fatigue is that, if a muscle is allowed to
contract, even after energy status has started to decrease, then
severe and irreversible damage may occur as a consequence of
a reduced energy status and an inability to effectively control
cytosolic Ca2 levels. When muscle excitability is reduced,
muscle activation is shut down at a very early stage in the
excitation-contraction coupling process, which effectively re-
duces not only the amount of ATP utilized by the contractile
apparatus but also ATP used for Ca2 recycling. Indeed,
Thabet et al. (42) observed severe damage to type IIb fibers
following treadmill running of mice deficient in KATP chan-
nels. Thus a link between metabolites and muscle excitability
may provide a feedback mechanism that effectively protects
muscle energy status and thus muscle integrity during intense
exercise.
Fig. 7. Correlation between force and M-wave parameters during 30-s, 60-Hz
continuous stimulation of control muscles. Corresponding data points of
tetanic force and M-wave area (A) and tetanic force and M-wave amplitude (B)
were correlated by linear regression lines of the equation Y  Y0  
X, where
Y0  15.9 and 
  1.12, r2  0.61, in A, and Y0  10.0 and 
  0.97, r2
 0.89, in B, respectively. P  0.001 for A and B. Dashed lines represent 95%
confidence intervals. Tetanic force, M-wave area, and M-wave amplitude are
shown as % initial control value (n  6).
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